CIK 0001541157 · Non-accelerated filer<br>Smaller reporting company
Akari Therapeutics Plc
Sign in to watch- Ticker
- AKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- EIN
- 981034922
- Phone
- (929) 274-7510
- Business address
- 401 EAST JACKSON STREET, SUITE 3300, TAMPA, FL, 33602
- Former names
- Celsus Therapeutics Plc., Morria Biopharmaceuticals PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-09-21 | Shaw Allan Director | Grant or award · Options to Purchase Ordinary Shares | +186,278 | 186,278 | ||
| 2015-09-21 | Hill James Director | Grant or award · Options (right to buy) | +231,278 | 231,278 | ||
| 2015-09-21 | Richardson Clive COO | Grant or award · Options (right to buy) | +16,271,850 | 16,271,850 | ||
| 2015-09-21 | Ungar Stuart Director | Grant or award · Options (right to buy) | +211,278 | 211,278 | ||
| 2015-09-21 | Cohen Mark S Director | Grant or award · Options to Purchase Ordinary Shares | +85,000 | 85,000 | ||
| 2015-09-21 | Cohen Mark S Director | Grant or award · Options to Purchase Ordinary Shares | +186,278 | 186,278 | ||
| 2015-09-21 | Elefant Dov Chief Financial Officer | Grant or award · Options to Purchase Ordinary Shares | +4,067,963 | 4,067,963 | ||
| 2015-09-21 | Roshwalb Gur Chief Executive Officer | Grant or award · Options to Purchase Ordinary Shares | +32,543,700 | 32,543,700 | ||
| 2015-09-18 | Cohen Mark S Director | Purchase | +1,055,600 | $0.19 | $200K | 1,055,600 |
| 2015-01-08 | Cohen Mark S Director | Option exercise | +50,700 | $0.02 | $847 | 50,700 |
| 2015-01-08 | Cohen Mark S Director | Option exercise | +152,000 | $0.02 | $2K | 152,000 |
| 2015-01-08 | Cohen Mark S Director | Option exercise · Options to Purchase Ordinary Shares | −50,700 | 0 | ||
| 2015-01-08 | Cohen Mark S Director | Option exercise · Options to Purchase Ordinary Shares | −152,000 | 0 | ||
| 2014-04-15 | SABBY MANAGEMENT, LLC 10% owner | Purchase | +17,100 | $5.00 | $86K | 778,030 |
| 2014-04-14 | SABBY MANAGEMENT, LLC 10% owner | Purchase | +3,000 | $5.21 | $16K | 760,930 |
| 2014-04-11 | SABBY MANAGEMENT, LLC 10% owner | Purchase | +100 | $5.15 | $515 | 757,930 |
| 2014-04-10 | SABBY MANAGEMENT, LLC 10% owner | Purchase | +1,400 | $5.25 | $7K | 757,830 |
| 2014-04-09 | SABBY MANAGEMENT, LLC 10% owner | Purchase | +1,075 | $5.51 | $6K | 756,430 |
| 2014-04-08 | SABBY MANAGEMENT, LLC 10% owner | Purchase | +35,500 | $5.36 | $190K | 755,355 |
| 2014-04-07 | SABBY MANAGEMENT, LLC 10% owner | Purchase | +16,900 | $5.64 | $95K | 716,101 |
Page 10 of 11 · 216 trades